References
- Baughman RP, Nunes H. Therapy for sarcoidosis: evidence-based recommendations. Expert Rev. Clin. Immunol. 8(1), 95–103 (2012).
- Hinz A, Fleischer M, Brähler E, Wirtz H, Bosse-Henck A. Fatigue in patients with sarcoidosis, compared with the general population. Gen. Hosp. Psychiatry 33(5), 462–468 (2011).
- Spruit MA, Thomeer MJ, Gosselink R et al. Hypogonadism in male outpatients with sarcoidosis. Respir. Med. 101(12), 2502–2510 (2007).
- Miyoshi T, Otsuka F, Takeda M et al. An elderly patient with sarcoidosis manifesting panhypopituitarism with central diabetes insipidus. Endocr. J. 54(3), 425–430 (2007).
- Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J. Fatigue is associated with quality of life in sarcoidosis patients. Chest 130(4), 989–994 (2006).
- Korenromp IH, Grutters JC, van den Bosch JM, Zanen P, Kavelaars A, Heijnen CJ. Reduced Th2 cytokine production by sarcoidosis patients in clinical remission with chronic fatigue. Brain Behav. Immun. 25(7), 1498–1502 (2011).
- Lower EE, Harman S, Baughman RP. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue. Chest 133(5), 1189–1195 (2008).
- Lower EE, Malhotra A, Surdulescu V, Baughman RP. Armodafinil for sarcoidosis-associated fatigue: a double‑blind, placebo-controlled, crossover trial. J. Pain Symptom Manage. doi:10.1016/j.jpainsymman.2012.02.016 (2012) (Epub ahead of print).